Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 10, 2020

SELL
$72.34 - $84.0 $211,956 - $246,120
-2,930 Closed
0 $0
Q1 2020

May 11, 2020

BUY
$62.63 - $80.22 $183,505 - $235,044
2,930 New
2,930 $219,000
Q3 2018

Nov 05, 2018

SELL
$71.28 - $78.92 $268,725 - $297,528
-3,770 Closed
0 $0
Q4 2017

Feb 07, 2018

BUY
$71.15 - $83.52 $10,672 - $12,528
150 Added 4.14%
3,770 $270,000
Q3 2017

Nov 09, 2017

BUY
$72.11 - $85.47 $261,038 - $309,401
3,620
3,620 $293,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Flossbach Von Storch Ag Portfolio

Follow Flossbach Von Storch Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flossbach Von Storch Ag, based on Form 13F filings with the SEC.

News

Stay updated on Flossbach Von Storch Ag with notifications on news.